Panacea Life Sciences Holdings
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Panacea Life Sciences Holdings's past years’ income statements indicate that its last revenue has increased compared to the previous period by 47% to $2,384,956. The net income raised on -$8,015,300 and profit margin reached -336%. Total operating expenses were $2,369,681.

Profit Margin

Panacea Life Sciences Holdings, Inc. (OTC:PLSH): Profit margin
2015 213 -357.97K -168064.32%
2016 0 -1.60M
2017 0 -3.86M
2018 0 -4.33M
2019 345.68K -9.48M -2742.81%
2020 9.01M -6.99M -77.57%
2021 2.05M -6.12M -297.35%
2022 1.62M -11.09M -682.14%
2023 2.38M -8.01M -336.08%

PLSH Income Statement (2015 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
2.38M1.62M2.05M9.01M345.68K000213
Cost of revenue
6.47M1.23M1.51M7.02M2.04M00020.62K
Gross profit
-4.08M396.47K540.57K1.99M-1.70M000-20.41K
Operating exp.
Research and development
000022.1K300K356.07K369.34K77.34K
Selling and marketing
17.94K209.25K377.91K638.63K254.86K0000
Total operating expenses
2.36M5.79M6.08M7.25M8.97M2.43M1.99M1.60M367.03K
Operating income
-5.54M-5.39M-5.54M-5.25M-10.67M-2.43M-1.99M-1.60M-368.44K
Other income (expenses), net
-2.46M-3.74M758.09K26.01K653.93K-1.90M-1.86M-1.45K10.46K
Income before tax
-8.01M-9.14M-4.78M-5.23M-10.01M-4.33M-3.86M-1.60M-357.97K
Income tax expense
01.95M1.34M1.76M-537.46K0-52.51K03
Net income
-8.01M-11.09M-6.12M-6.99M-9.48M-4.33M-3.86M-1.60M-357.97K
Earnings per share
Basic EPS
-0.48-0.75-0.34-0.41-7.83-0.91-25.47-0.08-156.61
Diluted EPS
-0.48-0.75-0.34-0.41-7.83-0.91-25.47-0.08-156.61
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source